Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 7/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | DHODH | Q02127 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA6 | P23280 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | KMO | O15229 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL46891 | 1.00 | PARP1 (0.61) | PARP1TSHRHSD17B10POLBCYP3A4 | |
| Terephthalamic Acid SCHEMBL28495422 | 0.91 | PARP1 (0.62) | PARP1TSHRHSD17B10POLBCYP3A4 | |
| Isophthalic Acid SCHEMBL8647102 | 0.90 | CA12 (0.62) | PARP1TSHRHSD17B10POLBCYP3A4 | |
| SCHEMBL36694 | 0.90 | PARP1 (0.73) | PARP1TSHRHSD17B10POLBCYP3A4 | |
| SCHEMBL31021028 | 0.90 | PARP1 (0.73) | PARP1TSHRHSD17B10POLBCYP3A4 | |
| SCHEMBL18397582 | 0.89 | KMO (0.70) | PARP1TSHRHSD17B10POLBCYP3A4 | |
| Water SCHEMBL7768285 | 0.87 | PARP1 (0.70) | PARP1TSHRHSD17B10POLBCYP3A4 | |
| Methane SCHEMBL688609 | 0.87 | PARP1 (0.70) | PARP1TSHRHSD17B10POLBCYP3A4 | |
| Hydrochloric Acid SCHEMBL1367509 | 0.87 | PARP1 (0.70) | PARP1TSHRHSD17B10POLBCYP3A4 | |
| Isophthalic Acid SCHEMBL4614187 | 0.87 | CA12 (0.65) | TSHRHSD17B10TDP1L3MBTL1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565599-B2 | Slurry, polishing method, and method for manufacturing semiconductor component | RESONAC CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| US-12522748-B2 | Slurry, polishing method, and method for producing semiconductor component | RESONAC CORPORATION (JP) | 2026-01-13 | — | — | US | disclosed |
| US-20230392043-A1 | SLURRY, POLISHING METHOD, AND METHOD FOR MANUFACTURING SEMICONDUCTOR COMPONENT | RESONAC CORPORATION (JP) | 2023-12-07 | — | — | US | disclosed |
| US-20230357600-A1 | SLURRY, POLISHING METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR COMPONENT | RESONAC CORPORATION (JP) | 2023-11-09 | — | — | US | disclosed |
| WO-2011009484-A1 | ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS | NOVARTIS AG (CH) | 2011-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565599-B2 | Slurry, polishing method, and method for manufacturing semiconductor component | STIP1, SGK1, SGK3 | PARP1 2623/4885TSHR 1506/4885HSD17B10 3930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.